2018
An Economic Evaluation of Coordinated Specialty Care (CSC) Services for First-Episode Psychosis in the U.S. Public Sector.
Murphy SM, Kucukgoncu S, Bao Y, Li F, Tek C, Breitborde NJK, Guloksuz S, Phutane VH, Ozkan B, Pollard JM, Cahill JD, Woods SW, Cole RA, Schoenbaum M, Srihari VH. An Economic Evaluation of Coordinated Specialty Care (CSC) Services for First-Episode Psychosis in the U.S. Public Sector. The Journal Of Mental Health Policy And Economics 2018, 21: 123-130. PMID: 30530872, PMCID: PMC6314808.Peer-Reviewed Original ResearchConceptsSpecialty care servicesPatient costsEarly intervention servicesUsual treatmentSchizophrenia spectrum disordersMonth 12Economic evaluationCare servicesSTEP participantsCommunity mental health centerThird-party payer perspectiveIntervention servicesFirst-episode servicesMonths post randomizationHealthcare service utilizationMental health centersU.S. public sectorTeam-based careCost-offset analysisEligible patientsThird-party payersAntipsychotic exposureED visitsMonth 6Episode psychosis
2014
High Rates of Obstructive Sleep Apnea Symptoms Among Patients With Schizophrenia
Annamalai A, Palmese LB, Chwastiak LA, Srihari VH, Tek C. High Rates of Obstructive Sleep Apnea Symptoms Among Patients With Schizophrenia. Journal Of The Academy Of Consultation-Liaison Psychiatry 2014, 56: 59-66. PMID: 25023923, PMCID: PMC5583522, DOI: 10.1016/j.psym.2014.02.009.Peer-Reviewed Original ResearchConceptsObstructive sleep apneaSevere mental illnessSTOP questionnaireSleep apneaHigh riskLarge urban community mental health centerMental illnessDiagnosis of OSAUrban community mental health centerCommunity mental health centerBody mass indexHigh-risk groupCross-sectional studyHigh clinical utilityMental health centersSample of outpatientsHigh rateOSA symptomsCardiovascular morbiditySurgical populationMass indexRisk factorsHealth centersSTOP scoreClinical utility
2009
Atypical Antipsychotics for People With Both Schizophrenia and Depression
Furtado VA, Srihari V, Kumar A. Atypical Antipsychotics for People With Both Schizophrenia and Depression. Schizophrenia Bulletin 2009, 35: 297-298. PMID: 19244590, PMCID: PMC2659320, DOI: 10.1093/schbul/sbn188.Peer-Reviewed Original Research
2008
Successful acamprosate treatment of alcohol dependence in schizophrenia
Tek C, Srihari V, Tek E. Successful acamprosate treatment of alcohol dependence in schizophrenia. Schizophrenia Research 2008, 106: 373. PMID: 18804961, DOI: 10.1016/j.schres.2008.08.010.Peer-Reviewed Original ResearchAtypical antipsychotics for people with both schizophrenia and depression
Furtado V, Srihari V, Kumar A. Atypical antipsychotics for people with both schizophrenia and depression. 2008, 2012: cd005377. PMID: 18254078, PMCID: PMC4171386, DOI: 10.1002/14651858.cd005377.pub2.Peer-Reviewed Original ResearchConceptsAtypical antipsychotic drugsAntipsychotic drugsGroup RegisterRelative riskCochrane Schizophrenia Group's RegisterNew atypical antipsychotic drugHomogenous dichotomous dataRelevant pharmaceutical companiesCo-morbid depressionConfidence intervalsTreatment of peopleLower depression scoresHaloperidol comparisonsTreat basisRandomised trialsAtypical antipsychoticsDATA COLLECTIONClinical trialsHamilton scorePANSS scoresDepression scoresDichotomous dataMean differenceMore trialsSchizophrenia